FDA applicant
Pentapharm, Ltd.
FDA records 3 decisions for Pentapharm, Ltd. (Washington, DC) from 2004 to 2010: 3 510(k) clearances. Most are in product codes GGN (Plasma, Coagulation Control) and GGW (Test, Time, Partial Thromboplastin). Its devices cite 3 predicates, 0 of them its own earlier devices. 2 recalls are linked to its devices.
FDA’s records also spell it “Pentapharm GmbH”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Pentapharm, Ltd.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2010
2026 so far, outlined.
Recalls per year
1in 2016
Class I Class II/III not classified
Planning a device like Pentapharm, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report